Advertisement
Original Articles| Volume 46, ISSUE 2, P229-238, July 15, 1999

Download started.

Ok

The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects

      Abstract

      Background: Efforts to model putative serotonergic deficits associated with affective disorders have frequently involved acute tryptophan depletion (ATD) as a manipulation strategy aimed at lowering brain serotonin synthesis. In an attempt to widen the scope of the measurement probes used in these investigations, the central actions of ATD and a subsequent dose of fenfluramine were examined via utilization of quantitative electroencephalography (EEG) and mood ratings.
      Methods: Electroencephalograms (EEG) and subjective mood ratings were assessed in 28 healthy men before and after double-blind ingestion of a tryptophan-depleting (T−) amino acid mixture, or a nutritionally balanced (B) amino acid mixture containing tryptophan, and again after a single-blind oral dose of d,l-fenfluramine hydrochloride (60 mg).
      Results: Compared to the B mixture, the T− mixture reduced total plasma tryptophan by more than 75% 5 hours after ingestion. Tryptophan depletion was associated with a modest lowering of mood and a slowing of EEG as indicated by increases in delta amplitude. Fenfluramine caused no change in mood but increased fast wave (beta) activity in anterior recordings when administered after the T−, but not after the B mixture.
      Conclusions: Quantitative EEG measurements may be a promising method for studying the central mechanisms underlying serotonin-mediated changes in mood and behavior.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abbott F.V.
        • Etienne P.
        • Franklin K.B.J.
        • Morgan M.J.
        • Sewitch M.J.
        • Young S.N.
        Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans.
        Psychopharmacology. 1992; 108: 60-66
        • Abt K.
        Descriptive data analysis.
        Methods Inf Med. 1987; 26: 77-88
        • Benkelfat C.
        • Ellenbogen M.A.
        • Dean P.
        • Palmour R.M.
        • Young S.N.
        Mood-lowering effect of tryptophan depletion.
        Arch Gen Psychiatry. 1994; 51: 687-697
        • Biggio G.
        • Fadda F.
        • Fanni P.
        • Tagliamonte A.
        • Gessa G.L.
        Rapid depletion of serum tryptophan brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet.
        Life Sci. 1974; 14: 1321-1329
        • Bond A.J.
        • Feizollah S.
        • Lader M.H.
        The effects of d-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function.
        J Psychopharmacol. 1995; 9: 1-8
        • Ceci A.
        • Baschirotto A.
        • Borsini F.
        Effect of fluoxetine on the spontaneous electrical activity of fronto-cortical neurons.
        Eur J Pharmacol. 1993; 250: 461-464
        • Cleare A.J.
        • Bond A.J.
        The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects.
        Psychopharmacology. 1995; 118: 72-81
        • Coccaro E.
        • Kavoussi R.
        • Cooper T.
        • Hauger R.
        Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
        Neuropsychopharmacology. 1996; 15: 595-596
        • Danjou P.
        • Hamon M.
        • Lacomblez L.
        • Warot D.
        • Kecskemeti S.
        • Puech A.J.
        Psychomotor, subjective and neuroendocrine effects of acute tryptophan depletion in the healthy volunteer.
        Psychiatr Psychobiol. 1990; 5: 31-38
        • Davidson R.
        Anterior electrophysiological asymmetries, emotion, and depression; Conceptual and methodological conundrums.
        Psychophysiology. 1998; 35: 607-614
        • Delgado P.L.
        • Charney D.S.
        • Price L.H.
        • Aghajanian G.K.
        • Landis H.
        • Heninger G.R.
        Serotonin function and the mechanism of antidepressant action.
        Arch Gen Psychiatry. 1990; 47: 411-418
        • Drevets W.C.
        • Raichle M.E.
        Neuroanatomical circuits in depression.
        Psychopharmacol Bull. 1992; 28: 261-274
        • Ellenbogen M.A.
        • Young S.N.
        • Dean P.
        • Palmour R.M.
        • Benkelfat C.
        Mood response to acute tryptophan depletion in healthy volunteers.
        Neuropsychopharmacology. 1996; 15: 465-474
        • Feeney S.
        • Goodall E.
        • Silverstone T.
        The effects of d- and l-fenfluramine and their interactions with d-amphetamine on psychomotor function and mood.
        Int Clin Psychopharmacol. 1996; 11: 89-99
        • Fink M.
        • Shapiro D.M.
        • Itil T.M.
        EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers.
        Psychopharmacologia. 1971; 22: 369-383
        • Fishbein D.H.
        • Lozovsky D.
        • Jaffe J.H.
        Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers.
        Biol Psychiatry. 1989; 25: 1049-1066
        • Foresta C.
        • Scanelli G.
        • Indino M.
        • Federspil G.
        • Scandellari C.
        Naloxone reduces the fenfluramine-induced prolactin release in man.
        Clin Endocrinol. 1985; 22: 539-543
        • Gessa G.L.
        • Biggio G.
        • Fadda F.
        • Corsini G.V.
        • Tagliamonte A.
        Effect of oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism.
        J Neurochem. 1974; 22: 869-870
        • Grünberger J.
        • Saletu B.
        • Linzmayer L.
        • Barbanoj M.J.
        Clinical-pharmacological study with the two isomers (d-,l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine.
        Meth Find Exp Clin Pharmacol. 1993; 15: 313-328
        • Heninger G.R.
        Indoleamines.
        in: Bloom F.E. Kupfer D.J. Psychopharmacology The Fourth Generation of Progress. Raven, New York1995: 471-482
        • Heninger G.R.
        • Delgado P.L.
        • Charney D.S.
        The revised monoamine theory of depression.
        Pharmacopsychiatry. 1996; 29: 2-11
        • Henriques J.B.
        • Davidson R.J.
        Left frontal hypoactivation in depression.
        J Abnorm Psychol. 1991; 100: 535-545
        • Henriques J.B.
        • Davidson R.J.
        Regional brain electrical asymmetries discriminate between previously depressed and healthy control subjects.
        J Abnorm Psychol. 1990; 99: 22-31
        • Herrmann W.M.
        Development and critical evaluation of an objective procedure for the electroencephalographic classification of psychotropic drugs.
        in: Herrmann W. Electroencephalography in Drug Research. Gustav Fischer, Stuttgart1982: 249-324
        • Herrmann W.M.
        • Schaerer E.
        Pharmaco-EEG.
        in: Lopes da Silva F. Handbook of Electroencephalography and Clinical Neurophysiology. Elsevier, Amsterdam1986: 385-445
        • Hrdina P.D.
        Platelet serotonergic markers in psychiatric disorders.
        J Psychiatr Neurosci. 1994; 19: 87-90
        • John E.R.
        • Prichep L.S.
        • Fridman J.
        • Easton P.
        Neurometrics.
        Science. 1988; 239: 162-169
        • Kano K.
        • Nakamura M.
        • Matsuoka T.
        • Iida H.
        • Nakajima T.
        The topographical features of EEGs in patients with affective disorders.
        EEG Clin Neurophysiol. 1992; 83: 124-129
        • Knott V.
        Functional utility of nicotine.
        in: Snel J. Lorist M. Nicotine, Caffeine and Social Drinking Behaviour and Brain Function. Harwood Academic Publishers, Amsterdam1998: 115-130
        • Knott V.
        • Harr A.
        • Ilivitsky V.
        EEG correlates of acute nicotinic and muscarinic cholinergic blockade.
        Hum Psychopharmacol. 1997; 12: 573-582
        • Knott V.J.
        • Lapierre Y.D.
        Computerized EEG correlates of depression and antidepressant treatment.
        Prog Neuropsychopharmacol Biol Psychiatry. 1987; 11: 213-221
        • Knott V.
        • Telner J.
        • Lapierre Y.D.
        • Browne M.
        • Horn E.
        Quantitative EEG in the prediction of antidepressant response to imipramine.
        J Affect Disord. 1996; 39: 175-184
        • Lam R.W.
        • Zis A.P.
        • Grewal A.
        • Delgado P.L.
        • Charney D.S.
        • Krystal J.H.
        Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy.
        Arch Gen Psychiatry. 1996; 53: 41-44
        • Lee S.
        • Buchsbaum M.
        Topographic mapping of EEG artifacts.
        Clin Electroencephalogr. 1987; 18: 61-67
        • Lewis D.A.
        • Sherman B.M.
        Serotonergic stimulation of adrenocorticotropin secretion in man.
        J Clin Endocrinol Metab. 1984; 58: 458-462
        • Leyton M.
        • Young S.N.
        • Blier P.
        • et al.
        The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder.
        Neuropsychopharmacology. 1997; 16: 294-297
        • Lichtenberg P.
        • Shapira B.
        • Blacker M.
        • Gropp C.
        • Calev A.
        • Lerer B.
        Effect of fenfluramine on mood.
        Biol Psychiatry. 1992; 31: 351-356
        • Lindsley D.
        Psychological phenomena and the EEG.
        EEG Clin Neurophysiol. 1951; 4: 443-456
        • Lorr M.
        • McNair D.M.
        • Fisher S.
        Evidence for bipolar mood states.
        J Pers Assess. 1982; 46: 432-436
        • Mann J.
        • Malone K.
        • Diehl D.
        • Perel J.
        • Nichols T.
        • Mintun M.
        Position emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers.
        J Cerebral Blood Flow Metab. 1996; 16: 418-426
        • McBride P.A.
        • DeMeo M.D.
        • Sweeney J.A.
        • Halper J.
        • Mann J.J.
        • Shear M.K.
        Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
        Biol Psychiatry. 1992; 31: 19-34
        • McClelland G.R.
        • Raptopoulos P.
        EEG and blood level of the potential antidepressant paroxetine after a single oral dose to normal volunteers.
        Psychopharmacology. 1984; 83: 327-329
        • McNair D.M.
        • Lorr M.
        • Droppleman L.F.
        Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego1988
        • Moja E.A.
        • Restani P.
        • Corsini E.
        • Stacchezzini M.C.
        • Assereto R.
        • Galli C.L.
        Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures.
        Life Sci. 1991; 49: 1121-1128
        • Monakhov K.
        • Perris C.
        Neurophysiological correlates of depressive symptomatology.
        Neuropsychobiol. 1980; 6: 268-279
        • Muldoon M.F.
        • Manuck S.B.
        • Jansma C.L.
        • Moore A.L.
        • Perel J.
        • Mann J.J.
        d,l-Fenfluramine challenge test.
        Biol Psychiatry. 1996; 39: 761-768
        • Myers J.E.
        • Mieczkowski T.
        • Perel J.
        • Abbondanza D.
        • Cooper T.B.
        • Mann J.J.
        Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders.
        Biol Psychiatry. 1994; 35: 112-120
        • Neumeister A.
        • Praschak-Rieder N.
        • Besselmann B.
        • Rao M.L.
        • Gluck J.
        • Kasper S.
        Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy.
        Arch Gen Psychiatry. 1997; 54: 133-138
        • Nieber D.
        • Schlegel S.
        Relationships between psychomotor retardation and EEG power spectrum in major depression.
        Neuropsychobiol. 1992; 25: 20-23
        • Nishizawa S.
        • Benkelfat C.
        • Young S.N.
        • et al.
        Differences between males and females in rates of serotonin synthesis in human brain.
        Proc Natl Acad Sci U S A. 1997; 94: 5308-5313
        • Nutt D.J.
        • Wilson S.J.
        • Coupland N.J.
        Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders.
        Int Clin Psychopharmacol. 1995; 9: 53-59
        • Nystrom C.
        • Matousek M.
        • Hallstrom T.
        Relationships between EEG and biochemical parameters in major depressive disorder.
        Acta Psychiatr Scand. 1988; 77: 457-462
        • Pollock V.E.
        • Schneider L.S.
        Quantitative, waking EEG research on depression.
        Biol Psychiatry. 1990; 27: 757-780
        • Price L.H.
        • Malison R.T.
        • McDougle C.J.
        • McCance-Katz E.F.
        • Owen K.R.
        • Heninger G.R.
        Neurobiology of tryptophan depletion in depression.
        Neuropsychopharmacology. 1997; 17: 342-350
        • Saletu B.
        The use of pharmaco-EEG in drug profiles.
        in: Hindmarch I. Stonier P. Human Psychopharmacology. volume 1. Wiley, Lichester1987: 173-200
        • Saletu B.
        • Barbanoj M.J.
        • Anderer P.
        • Sieghart W.
        • Grünberger J.
        Clinical-pharmacological study with the two isomers (d-,l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine.
        Meth Find Exp Clin Pharmacol. 1993; 15: 291-312
        • Saletu B.
        • Grünberger J.
        • Rajna P.
        Pharmaco-EEG profiles of antidepressants.
        Br J Clin Pharmacol. 1983; 15: 369S-383S
        • Sanders-Bush E.
        • Mayer S.E.
        5-Hydroxytryptamine (serotonin) receptor agonists and antagonists.
        in: Hardman J.G. Limbird L.E. Goodman and Gilman’s Pharmacological Basis of Therapeutics. 9th ed. McGraw-Hill, New York1996: 249-263
        • Schaffer C.E.
        • Davidson R.J.
        • Saron C.
        Frontal and parietal electroencephalogram asymmetry in depressed and nondepressed subjects.
        Biol Psychiatry. 1983; 18: 753-762
        • Schenk G.K.
        • Filler W.
        • Ranft W.
        • Zerbin D.
        Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables.
        Acta Psychiatr Scand. 1981; 290: 303-313
        • Sebban C.
        • Le Roch K.
        • Benkemoun G.
        • Debouzy C.
        • Baud P.
        Dexfenfluramine profile in quantitative EEG and its topographical aspects.
        in: Maurer K. Topographic Brain Mapping of EEG and Evoked Potentials. Springer-Verlag, Berlin1989: 288-295
        • Smith S.E.
        • Pihl R.O.
        • Young S.N.
        • Ervin F.R.
        A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males.
        Psychopharmacology. 1987; 91: 451-457
        • Stancampiano R.
        • Melis F.
        • Sarais L.
        • Cocco S.
        • Cugusi C.
        • Fadda F.
        Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo.
        Am J Physiol. 1997; 272: R991-R994
        • Trulson M.E.
        • Jacobs B.L.
        Raphe unit activity in freely moving cats.
        Brain Res. 1979; 163: 135-150
        • Vanderwolf C.H.
        • Baker G.B.
        Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior.
        Brain Res. 1986; 374: 342-356
        • Vanderwolf C.H.
        • Leung L.
        • Stewart D.J.
        Two afferent pathways mediating hippocampal rhythmical slow activity.
        in: Buzzaki G. Vanderwolf C.H. Electrical Activity of the Archicortex. Akademiai Kiado, Budapest1985: 47-66
        • Vanderwolf C.H.
        • Robinson T.E.
        • Pappas B.A.
        Monoamine replacement after reserpine.
        Brain Res. 1980; 202: 65-77
        • Weissman M.
        • Klerman G.
        Sex differences in the epidemiology of depression.
        Arch Gen Psychiat. 1977; 34: 98-111
        • Yatham L.N.
        • Steiner M.
        Neuroendocrine probes of serotonergic function.
        Life Sci. 1993; 53: 447-463
        • Young S.N.
        • Ervin F.R.
        • Pihl R.O.
        • Finn P.
        Biochemical aspects of tryptophan depletion in primates.
        Psychopharmacology. 1989; 98: 508-551
        • Young S.N.
        • Smith S.E.
        • Pihl R.O.
        • Ervin F.R.
        Tryptophan depletion causes a rapid lowering of mood in normal males.
        Psychopharmacology. 1985; 87: 173-177